New cell therapy tested for Tough-to-Treat cancers
NCT ID NCT07166263
Summary
This early study is testing a new cell therapy called NK510 for people with advanced stomach or colorectal cancer that has come back or stopped responding to standard treatments. The study will give NK510 through an IV or directly into the abdomen to see if it is safe and if it helps control the cancer. It will enroll about 15 adults whose cancer has progressed after at least two prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower Hospital, Affiliated to the Medical School of Nanjing University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.